Linked Life Data

15162819

Source:http://linkedlifedata.com/resource/pubmed/id/15162819

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2004-5-27
pubmed:abstractText
Current management modalities for intraocular retinoblastoma, their indications, and ocular prognosis are reviewed. Enucleation, external beam radiotherapy, plaque radiotherapy, laser photocoagulation and hyperthermia, and cryotherapy are the modalities generally employed. Recently, neoadjuvant chemotherapy has been introduced for retinoblastoma to avoid external beam radiotherapy. New treatment modalities such as subconjunctival injection, selective ophthalmic artery injection, and vitreous injection are being investigated and have achieved favorable results. Although many modalities are employed, almost half of retinoblastoma eyes have to be enucleated. New treatment modalities are expected.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1341-9625
pubmed:author
pubmed:issnType
Print
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1-6
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Management of intraocular retinoblastoma and ocular prognosis.
pubmed:affiliation
Division of Ophthalmology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. sgsuzuki@ncc.go.jp
pubmed:publicationType
Journal Article, Review, Research Support, Non-U.S. Gov't